MERTK and neoplasm: To investigate whether the delay in MerTK-overexpressing tumor growth observed in BALB/c mice is immune-mediated, we performed flow cytometry using 4T1 Vector, MerTK C8 and MerTK C11, and EMT6 Vector and MerTK C5 tumors for immune profiling at endpoint (day 27 or day 30 post-inoculation, respectively) (Figures 2D, E).